Mohamed Khadra

Professor Mohamed Khadra is Professor of Surgery in the Nepean Clinical School of Sydney Medical School at the University of Sydney, Faculty of Medicine and Health. He is Head of the Department of Urology at Nepean Hospital, Director of Surgery, and Director of Strategy and Innovation at Nepean Blue Mountains Local Health District. Previously, he served as Inaugural Chair of Surgery at the Australian National University, Pro-Vice-Chancellor for Health, Design and Science at the University of Canberra, and Professor and Head of the School of Rural Health at the University of New South Wales. He is co-founder of the Institute of Technology Australia, focused on delivering accessible higher education to students in developing countries. Khadra leads the Nepean Institute of Academic Surgery, a research-active group spanning urology, vascular surgery, general surgery, orthopaedics, surgical oncology, and other specialties, with emphasis on artificial intelligence, robotics in surgery, telehealth, surgical safety, quality improvement, and prostate cancer management.

Khadra earned a Bachelor of Medicine, Graduate Diploma in Computing, Master of Education from the University of Sydney in 1994, and PhD in Medicine from the University of Sydney in 1999, with a thesis titled 'The Role of the Hypogastric Nerve in the Control of Urinary Continence.' He holds fellowships as FRACS and FAICD, and was appointed Officer of the Order of Australia (AO) in 2017 for distinguished service to medicine in urology. His honors include the University of Sydney Alumni Award for Professional Achievement in 2015, Alumni Medal from the University of Newcastle, Noel Newton Medal for Surgical Research, and Alban Gee Prize in Urology. His research specializes in urological surgery, robotic-assisted radical prostatectomy, focal laser ablation for prostate cancer, artificial intelligence applications in urology, and telehealth for chronic diseases, with over 750 citations. Key publications are 'Focal laser ablation in prostate cancer: a systematic review and meta-analysis' (2025), 'Comparing outcomes of robotic-assisted radical prostatectomy by specialists and trainees using a modular training approach' (2025), 'Bibliometric analysis on current trends of artificial intelligence application in Urology' (2025), 'Focal therapy using a novel cooled laser device for prostate cancer: early trial results' (2026), and 'Artificial intelligence in urology: a technology with transformative potential' (2024). He authored bestsellers Making the Cut (2007), The Patient (2009), and Terminal Decline (2010), and co-authored the play At What Cost? with David Williamson.

Professional Email: mohamed.khadra@sydney.edu.au